New drug shows promise for severe eczema in major trial
NCT ID NCT06477835
Summary
This study tested whether a new drug called SIM0718 is effective and safe for treating moderate to severe atopic dermatitis (eczema). It involved 259 teenagers and adults whose eczema was not well-controlled with standard creams. Participants were randomly assigned to receive either SIM0718 or a placebo (dummy treatment) for 16 weeks to see which group had better skin clearance and symptom relief.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.